INBX vs PFG · rev $1.3M vs P/E 16, rev $15.63B
Inhibrx Biosciences, Inc. (INBX) versus Principal Financial Group Inc (PFG) — a side-by-side from cached financials, not a winner call.
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
Principal Financial Group Inc (PFG) is a asset management company listed on NASDAQ.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
Latest reported PFG revenue for 2025-12-31 was $15.63B. Net income was $1.19B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. PFG currently screens at market cap $23.81B and trailing P/E 15.8.
INBX currently screens at market cap $1.28B. PFG currently screens at market cap $23.81B and trailing P/E 15.8.
Not investment advice. Open the INBX and PFG stock pages for the full models.
Not investment advice.